Aoxin Medical showcases innovative achievements at the North American Society of Radiology, promoting the internationalization of high-end medical imaging equipment

Update Date:2024-12-09
On December 1st, 2024, the annual feast of the global medical imaging community, the Radiological Society of North America (RSNA), was grandly held in Chicago, USA, attracting over 70000 experts, scholars, and technicians from more than 150 countries to attend. Shandong Aoxin Medical Technology Co., Ltd. participated in this grand event with the world's first 3.0T limb joint magnetic resonance imaging device developed through independent innovation, which is also the first appearance of this high-end medical imaging equipment on the international stage. Its advanced technology and excellent imaging performance have been highly praised by domestic and foreign experts and scholars attending the conference.
As the most influential academic conference in the global radiology field, Aoxin Medical has chosen to showcase its flagship products on this platform, marking an important layout of the company's internationalization strategy and demonstrating the increasing competitiveness of China's specialized high-end medical imaging equipment in the global market.
The development and promotion of 3.0T limb joint magnetic resonance equipment has been a key project of Aoxin Medical in recent years. This device is designed for precise imaging of limb joints and can play an important role in early diagnosis of common diseases such as osteoarthritis and cartilage damage. Compared to traditional open magnetic resonance equipment, Aoxin Medical's product has significantly improved field strength, gradient switching rate, and software processing capabilities, greatly improving image quality and providing more reliable basis for clinical diagnosis and treatment.
According to Mr. Li Peiyong, General Manager of Aoxin Medical, this 3.0T limb joint magnetic resonance equipment has undergone multiple rounds of technical research and experimental optimization. The launch of the equipment not only meets the domestic market demand, but also caters to the international pursuit of high-precision medical imaging equipment. Through communication and exchange with multiple internationally renowned medical institutions, Aoxin Medical continuously listens to feedback from frontline users, optimizes product applications, and ensures its universality and efficiency in different regions around the world.
The newly developed 1.5T large aperture interventional magnetic resonance imaging has received high attention and appreciation from medical imaging experts and scholars around the world. Mr. Philippe Gerson, Financial Officer of the International Society of Radiographers, and Mr. Naoki Koyama, Vice President of the Japan Association of Radiographers, publicly stated that "1.5T large aperture interventional magnetic resonance imaging not only demonstrates China's rapid development and progress in the field of high-end medical imaging equipment, but also brings good news to the global medical field." In addition, many internationally renowned imaging experts have highly praised the high performance of this product and expressed their expectation for deeper academic exchanges and technical cooperation with Aoxin Medical in the future.
The annual meeting of the North American Society of Radiology provided a stage for Aoxin Medical to compete with other top brands, and the company also took this opportunity to showcase the technological innovation capabilities of Chinese brands with its strength. Exhibiting is not just about showcasing products, but also about building closer relationships with global customers through international exchanges, laying a solid foundation for future international cooperation.
With the intensification of the global aging trend and the booming development of the healthcare industry, high-quality medical imaging equipment is receiving increasing attention. By participating in this grand event, Aoxin Medical not only enhances its international influence, but also paves the way for further exploration and development of the international market. Looking ahead to the future, Aoxin Medical will continue to uphold the spirit of technological innovation, strengthen scientific research and development, and contribute more to the global healthcare industry.